Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $16,033 - $26,164
71 Added 1.87%
3,871 $983,000
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $3.57 Million - $7.79 Million
-16,084 Reduced 80.89%
3,800 $1.46 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $1.1 Million - $2.85 Million
16,784 Added 541.42%
19,884 $2.08 Million
Q3 2020

Nov 16, 2020

SELL
$54.34 - $94.85 $2.74 Million - $4.79 Million
-50,484 Reduced 94.21%
3,100 $219,000
Q2 2020

Aug 14, 2020

BUY
$29.67 - $80.0 $1.29 Million - $3.47 Million
43,358 Added 424.0%
53,584 $3.44 Million
Q1 2020

May 15, 2020

BUY
$17.78 - $31.58 $181,818 - $322,937
10,226 New
10,226 $306,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.